166 related articles for article (PubMed ID: 27915085)
1. Monocyte-derived circulating microparticles (CD14
Chiva-Blanch G; Bratseth V; Ritschel V; Andersen GØ; Halvorsen S; Eritsland J; Arnesen H; Badimon L; Seljeflot I
Int J Cardiol; 2017 Jan; 227():876-881. PubMed ID: 27915085
[TBL] [Abstract][Full Text] [Related]
2. Platelet-, monocyte-derived and tissue factor-carrying circulating microparticles are related to acute myocardial infarction severity.
Chiva-Blanch G; Laake K; Myhre P; Bratseth V; Arnesen H; Solheim S; Badimon L; Seljeflot I
PLoS One; 2017; 12(2):e0172558. PubMed ID: 28207887
[TBL] [Abstract][Full Text] [Related]
3. Circulating microparticles are associated with clinical severity of persistent ST-segment elevation myocardial infarction complicated with cardiogenic shock.
Sionis A; Suades R; Sans-Roselló J; Sánchez-Martínez M; Crespo J; Padró T; Cubedo J; Ferrero-Gregori A; Vila-Perales M; Duran-Cambra A; Badimon L
Int J Cardiol; 2018 May; 258():249-256. PubMed ID: 29544939
[TBL] [Abstract][Full Text] [Related]
4. CD142+/CD61+, CD146+ and CD45+ microparticles predict cardiovascular events in high risk patients following a Mediterranean diet supplemented with nuts.
Chiva-Blanch G; Crespo J; Suades R; Arderiu G; Padro T; Vilahur G; Cubedo J; Corella D; Salas-Salvadó J; Arós F; Martínez-González MA; Ros E; Fitó M; Estruch R; Badimon L
Thromb Haemost; 2016 Jul; 116(1):103-14. PubMed ID: 27052787
[TBL] [Abstract][Full Text] [Related]
5. The Kinetics of Circulating Monocyte Subsets and Monocyte-Platelet Aggregates in the Acute Phase of ST-Elevation Myocardial Infarction: Associations with 2-Year Cardiovascular Events.
Zhou X; Liu XL; Ji WJ; Liu JX; Guo ZZ; Ren D; Ma YQ; Zeng S; Xu ZW; Li HX; Wang PP; Zhang Z; Li YM; Benefield BC; Zawada AM; Thorp EB; Lee DC; Heine GH
Medicine (Baltimore); 2016 May; 95(18):e3466. PubMed ID: 27149446
[TBL] [Abstract][Full Text] [Related]
6. High levels of TSP1+/CD142+ platelet-derived microparticles characterise young patients with high cardiovascular risk and subclinical atherosclerosis.
Suades R; Padró T; Alonso R; Mata P; Badimon L
Thromb Haemost; 2015 Nov; 114(6):1310-21. PubMed ID: 26178021
[TBL] [Abstract][Full Text] [Related]
7. Circulating microparticle signature in coronary and peripheral blood of ST elevation myocardial infarction patients in relation to pain-to-PCI elapsed time.
Suades R; Padró T; Crespo J; Ramaiola I; Martin-Yuste V; Sabaté M; Sans-Roselló J; Sionis A; Badimon L
Int J Cardiol; 2016 Jan; 202():378-87. PubMed ID: 26432487
[TBL] [Abstract][Full Text] [Related]
8. Growing thrombi release increased levels of CD235a(+) microparticles and decreased levels of activated platelet-derived microparticles. Validation in ST-elevation myocardial infarction patients.
Suades R; Padró T; Vilahur G; Martin-Yuste V; Sabaté M; Sans-Roselló J; Sionis A; Badimon L
J Thromb Haemost; 2015 Oct; 13(10):1776-86. PubMed ID: 26239059
[TBL] [Abstract][Full Text] [Related]
9. Admission Low-Density Lipoprotein Cholesterol Stratified by Circulating CD14++CD16+ Monocytes and Risk for Recurrent Cardiovascular Events Following ST Elevation Myocardial Infarction: Lipid Paradox Revised.
Dong S; Ji W; Zeng S; Miao J; Yan L; Liu X; Liu J; Zhou X; Yang Q
J Cardiovasc Transl Res; 2020 Dec; 13(6):916-927. PubMed ID: 32557321
[TBL] [Abstract][Full Text] [Related]
10. Monocyte heterogeneity in myocardial infarction with and without ST elevation and its association with angiographic findings.
Arslan U; Kocaoğlu I; Balci MM; Gülkan B; Falay MY; Temizhan A
Coron Artery Dis; 2013 Aug; 24(5):404-11. PubMed ID: 23612365
[TBL] [Abstract][Full Text] [Related]
11. Microparticles during long-term follow-up after acute myocardial infarction. Association to atherosclerotic burden and risk of cardiovascular events.
Christersson C; Thulin Å; Siegbahn A
Thromb Haemost; 2017 Jul; 117(8):1571-1581. PubMed ID: 28424820
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of Activated Monocytes in Patients with ST-Elevation Myocardial Infarction.
Abo-Aly M; Shokri E; Chelvarajan L; Tarhuni WM; Tripathi H; Abdel-Latif A
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511100
[TBL] [Abstract][Full Text] [Related]
13. Trajectories of Circulating Monocyte Subsets After ST-Elevation Myocardial Infarction During Hospitalization: Latent Class Growth Modeling for High-Risk Patient Identification.
Zeng S; Yan LF; Luo YW; Liu XL; Liu JX; Guo ZZ; Xu ZW; Li YM; Ji WJ; Zhou X
J Cardiovasc Transl Res; 2018 Feb; 11(1):22-32. PubMed ID: 29313268
[TBL] [Abstract][Full Text] [Related]
14. Small-size circulating microparticles in acute coronary syndromes: relevance to fibrinolytic status, reparative markers and outcomes.
Montoro-García S; Shantsila E; Tapp LD; López-Cuenca A; Romero AI; Hernández-Romero D; Orenes-Piñero E; Manzano-Fernández S; Valdés M; Marín F; Lip GY
Atherosclerosis; 2013 Apr; 227(2):313-22. PubMed ID: 23415055
[TBL] [Abstract][Full Text] [Related]
15. Pattern of endothelial progenitor cells and apoptotic endothelial cell-derived microparticles in chronic heart failure patients with preserved and reduced left ventricular ejection fraction.
Berezin AE; Kremzer AA; Martovitskaya YV; Berezina TA; Gromenko EA
EBioMedicine; 2016 Feb; 4():86-94. PubMed ID: 26981573
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of admission red cell distribution width-to-platelet ratio in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Pusuroglu H; Cakmak HA; Akgul O; Erturk M; Surgit O; Akkaya E; Bulut U; Yildirim A
Rev Port Cardiol; 2015 Oct; 34(10):597-606. PubMed ID: 26387826
[TBL] [Abstract][Full Text] [Related]
17. Circulating CD45+/CD3+ lymphocyte-derived microparticles map lipid-rich atherosclerotic plaques in familial hypercholesterolaemia patients.
Suades R; Padró T; Alonso R; López-Miranda J; Mata P; Badimon L
Thromb Haemost; 2014 Jan; 111(1):111-21. PubMed ID: 24085382
[TBL] [Abstract][Full Text] [Related]
18. Natriuretic peptides, nitrite/nitrate and superoxide dismutase have additional value on top of the GRACE score in prediction of one-year mortality and rehospitalisation for heart failure in STEMI patients - Multiple biomarkers prospective cohort study.
Parenica J; Kala P; Pavkova MG; Tomandl J; Spinar J; Littnerova S; Jarkovsky J; Mebazaa A; Tomandlova M; Dastych M; Gottwaldova J; Gayat E
Int J Cardiol; 2016 May; 211():96-104. PubMed ID: 26991556
[TBL] [Abstract][Full Text] [Related]
19. Role of cathepsin D activation in major adverse cardiovascular events and new-onset heart failure after STEMI.
Yamac AH; Sevgili E; Kucukbuzcu S; Nasifov M; Ismailoglu Z; Kilic E; Ercan C; Jafarov P; Uyarel H; Bacaksiz A
Herz; 2015 Sep; 40(6):912-20. PubMed ID: 25911051
[TBL] [Abstract][Full Text] [Related]
20. The relationship between admission monocyte HDL-C ratio with short-term and long-term mortality among STEMI patients treated with successful primary PCI.
Çiçek G; Kundi H; Bozbay M; Yayla C; Uyarel H
Coron Artery Dis; 2016 May; 27(3):176-84. PubMed ID: 26751423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
